Summary This study investigated the effects of the consumption of 1% or 2% (v/v) ethanol in drinking water for 12 wk on rats fed a high-fat diet. Body weight gain, food intake, and fluid intake were unaffected by ethanol intake. Adipose tissue weight, and serum glucose and lipids were unaffected. Compared to the control (no ethanol), 1% ethanol intake significantly reduced serum levels of alanine aminotransferase (ALT), lactate dehydrogenase (LDH), and ammonia (p,0.05), whereas 2% ethanol intake did so to a lesser extent. Serum urate was significantly lower in both the 1% and 2% ethanol groups than that in the control group (p,0.05). The results suggest a low dose of ethanol has beneficial effects on liver function and serum urate in rats fed a high-fat diet.
High alcohol intake has harmful effects on health. Conversely, epidemiological studies suggest moderate alcohol intake has multiple beneficial effects (1, 2) . The epidemiological study of Marmot and Brunner in 1991 revealed a J-shaped relationship between alcohol intake and the risks of mortality due to cardiovascular disease and cancer (3) . Since then, several epidemiological studies have suggested light to moderate alcohol intake confers multiple beneficial effects including risk reduction of several diseases such as type 2 diabetes, brain infarction, and liver cirrhosis (1) (2) (3) (4) (5) . However, the inherent limitations of epidemiological studies mean they cannot confirm whether alcohol intake itself is the direct cause of the observed effect or possesses biological activity; other factors may be at play, such as ethnicity, type of beverage, drinking style, social class, lifestyle, physical activity, and personality type.
Although accumulating epidemiological evidence indicates moderate alcohol intake has beneficial effects on health, there is limited information regarding the effects of low alcohol intake in animal studies. A recent study indicates the consumption of 1% ethanol in drinking water decreases risk factors for cardiovascular events in rats, such as serum cholesterol, triglyceride, and catecholamine metabolism in the peripheral system (6). Fromenty et al. report glycemia and insulinemia in ob/ob mice are significantly reduced as a result of 1.5% ethanol in drinking water (7) . These results suggest low doses of alcohol have protective effects against cardiovascular disease and diabetes.
A high-fat diet is associated with several health problems such as obesity, hyperlipidemia, diabetes, and nonalcoholic fatty liver disease. Accordingly, the present study investigated the effect of low ethanol consumption on the circulating and hepatic biochemical parameters of rats fed a high-fat diet.
MATERIALS AND METHODS

Animals and diets.
Male Sprague-Dawley rats were maintained according to the Guide for the Care and Use of Laboratory Animals established by Hiroshima University. The rats were individually housed in metal cages in a temperature-controlled (2461˚C) room with a 12-h light/dark cycle. They had free access to diet and drinking water. After consuming a commercial stock diet (MF, Oriental Yeast Co., Ltd., Tokyo, Japan) for 1 wk, the rats (mean weight: 106 g) were divided into 3 groups of 14-15 rats each. The rats had free access to a high-fat diet and deionized water, 1% (v/v) ethanol, or 2% (v/v) ethanol. The basal diet comprised 30% beef tallow, 20% casein, 0.2% l-cystine, 5% cellulose, 20% sucrose, 1% vitamin mixture, and 3.5% salt mixture (made up to 100% by corn starch) (8) . The experimental feeding period was 12 wk. Food intake and body weight were measured daily. After the end of the feeding period, the diet was removed from the cages at 0800 h, and the animals were sacrificed from 1300-1500 h by decapitation under anesthesia with diethyl ether. Blood was collected, and serum was separated by centrifugation at 2,000 3g for 20 min and stored at 280˚C. Several tissues were immediately obtained and stored at 220˚C until analysis.
Blood parameters. Blood hemoglobin, serum alkaline phosphatase (ALP), urea, and albumin were quantified using commercially available kits (Wako Pure Chemical Industries, Ltd., Osaka, Japan). Serum acetate and ethanol were quantified with an F-kit (Boehringer, Mannheim, Germany Other serum parameters were analyzed using a Beckman Coulter AU480 analyzer (Beckman Coulter, Krefeld, Germany), which is an automated chemistry instrument for turbidimetric, spectrophotometric, and ion-selective electrode measurements. Briefly, 200 mL serum was used to measure alanine aminotransferase (ALT), aspartate transaminase (AST), gamma-glutamyl transpeptidase (g-GTP), total bilirubin, ammonia, lactate dehydrogenase (LDH), urea, creatine, Fe, Mg, Ca, lactate, glucose, total cholesterol, high-density lipoprotein-cholesterol, free fatty acid and triglyceride according to the manufacturer's protocol. Liver triglyceride and thiobarbituric acid-reactive substances. Liver lipids were extracted according to the method of Folch et al. (9) . The concentration of triglycerides was quantified with a kit. An assay for thiobarbituric acid-reactive substances (TBARS) in the liver, lungs, and kidneys was performed as described by Ohkawa et al. (10) .
Statistical analyses. Data are expressed as means6 SE. Statistical analysis was performed with one-way ANOVA, followed by Dunnet's test. Student's t-test was used to analyze the data on ethanol intake between the 1% ethanol and 2% ethanol groups. Statistical significance of the difference among means was estimated at p,0.05.
RESULTS
Ethanol ingestion did not affect final body weight or body weight gain for 12 wk (Table 1) . Food intake for 12 wk was unaffected by ethanol intake. Fluid intake did not differ among the 3 groups at 28, 56, or 84 d ( Table  1 ). The weights of tissues including the liver, epididymal adipose tissue, perirenal adipose tissue, and gastrocnemius muscle were unaffected by ethanol ingestion (Table 1) .
Serum parameters related to liver damage are shown in Table 2 . Compared to the control group, the serum level of ALT was significantly lower in both the 1% and 2% ethanol groups (216% and 211%, p,0.05, respectively, Table 2 ), more so in the 1% ethanol group. The serum level of ammonia was significantly lower in both the 1% and 2% ethanol groups than the control group (211% and 210%, p,0.05, respectively). The serum level of LDH was significantly lower in the 1% ethanol group than the control group (225%, p,0.05), but there was no difference between the control and 2% ethanol groups. The serum levels of AST, g-GTP, total bilirubin and albumin were unaffected by ethanol intake ( Table 2) . Compared to the control group, serum urate was significantly lower in both the 1% and 2% ethanol groups (212% and 214%, p,0.05, respectively) ( Table 3 ). There were no significant effect of ethanol intake on other blood parameters including urea, ALP, creatinine, Fe, Mg, Ca, lactate, acetate, ethanol, TNF-a, nitrate, adiponectin, IGFBP-1 and hemoglobin (Table 3) . Serum glucose and lipids, and liver triglyceride and TBARS were unaffected by ethanol intake (Table 4) . Ethanol intake did not affect the levels of TBARS in the lungs and kidneys (data not shown).
DISCUSSION
Lieber-DeCarli liquid diet containing 36% of energy from ethanol has been widely used to investigate the harmful effects of high doses of ethanol on the liver in rats (11) . In the present study, rats were given water containing 1% ethanol, which is approximately equivalent to 2% of energy intake from ethanol (the energy content of ethanol was assumed to be 7 kcal/g); this dose is far less than that of the Lieber-DeCarli liquid diet (11) . Our results showed 1% ethanol intake in rats fed a high-fat diet significantly lowered serum parameters related to liver damage, such as ALT, LDH, and ammonia, while 2% ethanol intake did so to a lesser extent. Liver and gut microflora are the main sources of blood ammonia (12) . Because the cecal concentration of ammonia was unaffected (Osaki, unpublished data), the reduction in serum ammonia by 1% ethanol intake appears to be related to the improvement in liver function. These results suggest low doses of ethanol, especially 1% ethanol, have beneficial effects on liver function. Our results are consistent with the study indicating modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (13) . LDH is also well known as a biomarker of damage of several other tissues such as heart, muscle, and lung. Thus, the possibility of a beneficial effect of 1% ethanol intake on such tissues remains. However, in the present study, 1% alcohol intake did not affect other indices of liver function, such as serum AST, g-GTP, total bilirubin, albumin, or ALP. The reason for this apparent lack of effect is unknown. Recent accumulating evidence indicates that the ratio of serum levels of AST to ALT depends on the type of liver disease such as viral hepatitis, alcoholic hepatitis, and non-alcoholic fatty liver disease, as well as the time course and aggressiveness of the disease (14) . Therefore, it is necessary to examine the effects of a low dose of ethanol on several liver diseases as well as disease progression and aggressiveness.
As a 1% ethanol intake had a beneficial effect on liver function in the present study, it is of interest to extrapolate the results to humans. The average body weight of 17-wk-old rats with a daily ethanol intake of ~0.30 g was ~550 g. As it is well known, rats metabolize ethanol 3 times faster than humans, 300 mg/kg body weight/h in rats (15) versus 100 mg/kg body weight/h in humans (16) . Therefore, the daily dose of ethanol intake in rats is approximately equivalent to 11 g ethanol/d in a standard human male weighing 60 kg. In an epidemiological study by Di Castelnuovo et al. (17) , 2.5-15 g ethanol/d appears to be associated with the lowest total mortality in human males. Thus, the dose of ethanol in the 1% ethanol group is well within the protective doses suggested by the above-mentioned epidemiological study (17) . However, this extrapolation method appears to be based on the overly simplified assumption that rats metabolize ethanol 3 times faster than humans (15, 16) . Therefore, further information comparing the effects of alcohol dose in humans and rats is necessary.
As the level of TBARS in the liver was unaffected, the protective effect of 1% ethanol intake appears to be mediated through mechanisms not involving oxidative stress. A recent study indicates 1% ethanol intake in drinking water reduces the level of liver lipid peroxides (TBARS) in rats (6) , although the parameters of liver injury are unaffected. The source of the discrepancy between the results of their study and our study is unknown. There are differences in the experimental conditions such as diet (previous vs. present study: standard solid diet vs. high-fat diet), initial body weights (270-310 g vs. average, 106 g), and feeding period of ethanol (30 d vs. 12 wk). Previous studies show that a high-fat diet increases TBARS levels in the liver of Sprague-Dawley rats compared to a normal diet (18) . Thus, the elevation in tissue TBARS caused by a high-fat diet may abolish the anti-oxidative effect of 1% ethanol intake.
The present study also provides evidence that low doses of ethanol (both 1% and 2%) can lower serum urate level. As urate is synthesized mainly in the liver, the effect of ethanol on serum urate might be mediated through its effect on the liver. Modest alterations in the production, solubility, or excretion of urate can cause hyperuricemia. Previous studies show hyperuricemia is a risk factor for gout, cancer, and components of metabolic syndrome, such as hypertension and insulin resistance (19) (20) (21) . Epidemiological studies suggest moderate alcohol intake reduces the risks of diseases such as cancers, diabetes, and cardiovascular diseases (1, 2) . Thus, it is of interest to determine if the reduction in the risks of such diseases by ethanol is at least in part mediated through decreased serum urate. However, further study is required to elucidate the regulatory mechanisms of serum urate by low doses of ethanol.
Cell culture studies indicate ethanol treatment induces expression of insulin-like growth factor binding protein-1 (IGFBP1-1) (22) . Recent studies suggest IGFBP-1 plays a role as a protective factor against liver injury, type 2 diabetes, hypertension, atherosclerosis, and cancer (23) (24) (25) . Adiponectin is also known to be a protective factor against such diseases, including liver injury (26) . Therefore, we hypothesized the protective effect of a low dose of ethanol is mediated through alterations in serum IGFBP-1 and adiponectin. The results, however, indicated no differences in these parameters among the 3 groups, denying the hypothesis. The serum level of TNF-a, a pro-inflammatory cytokine, was also unaffected. Furthermore, other serum parameters such as glucose and lipids were also unaffected by alcohol intake in the present study. These results are inconsistent with those of previous studies (6, 7) indicating low doses of alcohol decrease blood glucose and lipids in rats and mice. One of the major differences between the present and previous studies appears to be the dietary composition: the present study used a high-fat diet, while other studies used standard solid diets. Therefore, further study is required to determine the reason for this discrepancy.
In conclusion, the present study indicates 1% ethanol intake has beneficial effects on liver function and on serum urate in rats fed a high-fat diet. Intriguingly, 1% ethanol intake had greater beneficial effects on liver function than 2% ethanol intake. This finding appears to be in favor of the putative protective effect of lower alcohol consumption against health problems. Nevertheless, further studies are required to elucidate the underlying mechanisms of the beneficial effects of 1% ethanol intake.
